179
Views
7
CrossRef citations to date
0
Altmetric
Articles

Metabolites of isocorynoxeine in rats after its oral administration

, , , , &
Pages 384-390 | Received 08 Oct 2013, Accepted 25 Dec 2014, Published online: 30 Jan 2015
 

Abstract

This work presents the metabolites of isocorynoxeine (ICOR), which is one of four bioactive tetracyclic oxindole alkaloids isolated from Uncaria hooks used commonly in the traditional Chinese medicines and Kampo medicines. After oral administration of 40 mg kg− 1 ICOR to rats, bile was drained and analyzed by LC-MS. Two phase I metabolites, namely 11-hydroxyisocorynoxeine (M1) and 10-hydroxyisocorynoxeine (M2), and two phase II metabolites, namely 11-hydroxyisocorynoxeine 11-O-β-d-glucuronide (M3) and 10-hydroxyisocorynoxeine 10-O-β-d-glucuronide (M4), were isolated from rat excreta and bile, respectively, whose structures were elucidated on the basis of CD, NMR, and MS.

Additional information

Funding

This work was sponsored by the 44th Batch of Scientific Research Foundation for the Returned Overseas Chinese Scholars (to WW), State Education Ministry, China, also financially supported by Yunnan Provincial Research Program of Application Foundation [general grant number 2012FB154], [general grant number 2013FZ061], [general grant number 2013FB121]; Yunnan Provincial Education Bureau Research Foundation [grant number 2014Y158], [2013Y296].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.